Introduction: Lipodystrophy is a term used to describe a metabolic complication of fat loss, fat
gain, or a combination of fat loss and gain, which is associated with some antiretroviral …

Background People with HIV infection are at increased risk of noncommunicable diseases
(NCDs). Diabetes mellitus (DM) and hypertension are recognized as the major NCDs …

The use of highly active antiretroviral therapy (HAART) has extremely enhanced the clinical
outcome of HIV disease with a decrease in mortality and morbidity. However, the inclusion of …

Objetivo Avaliar a associação entre a qualidade de vida e a adesão ao tratamento
antirretroviral. Métodos Estudo transversal, desenvolvido em serviço ambulatorial de …

Background Development of emotional distress (ED) among adolescents living with
perinatally acquired HIV (ALPHIV) affects their adherence behaviour and social and …

There are increasing researches about non-communicable disease such as elevated blood
pressure among people living with HIV before and after initiation of highly active …

Results: The quality of life domains that affect adherence positively were those related to
general function, medication concerns and confidence in the health professional. The …

Long-term survival of treated people living with HIV (PLWH) currently approaches that of the
general population. The average age of PLWH is currently in the mid-50s in resource-rich …

Background Lipodystrophy (LD) is a frequent adverse event of combination antiretroviral
therapy (ART) and occurs mainly in patients exposed to first-generation antiretroviral drugs …

The development of antiretroviral (ARV) drugs to treat HIV has turned what was once a
death sentence into a chronic disorder. However, a focus on absence of disease in the form …